Furthermore, we identified a promising small molecule hit (GY1-22) after screening a drug-like library against DNAJA1-mutP53R175H interacting pocket, which can inhibit mutp53-driven pancreatic cancer cell growth both in vitro and in vivo. Here, DNAJA1 is linked to pancreatic neoplasm.